Fiscal Year: January - December
UnitedHealth Group Incorporated (UNH), listed on the NYSE, has a market capitalization of $. As of Jan 06, 2026, the stock is trading at $342.02 per share, offering investors a clear view of its current market value. UnitedHealth Group Incorporated is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 17.8, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. UnitedHealth Group Incorporated also offers a dividend yield of 2.63%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that UnitedHealth Group Incorporated (UNH) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for UnitedHealth Group Incorporated is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for UnitedHealth Group Incorporated, Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for UnitedHealth Group Incorporated is 17.83, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, UnitedHealth Group Incorporated (UNH) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether UnitedHealth Group Incorporated (UNH) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of UnitedHealth Group Incorporated (UNH) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of UnitedHealth Group Incorporated. To access the full SS Score, consider upgrading your subscription.
UnitedHealth Group Incorporated is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 17.8. Investors should compare these metrics with industry peers to gauge whether UnitedHealth Group Incorporated is outperforming or underperforming within its sector.
Spending on executive protection is up, and it isn't all bodyguards and trained drivers.
The Dow Jones Industrial Average hit record all-time highs in 2025 with many of the components ending the year higher. Along with serving as a well-known barometer of overall market health, the index ...
Carter Worth, Worth Charting, joins 'Fast Money' to talk what's ahead for UnitedHealthcare.
UnitedHealth Group sentiments have found their footing after significant declines, aided by sector recovery and Berkshire Hathaway's confidence-boosting purchase. UNH remains reasonably valued compare...
Sarat Sethi, DCLA, joins 'Closing Bell Overtime' to talk stocks that are struggling heading into 2026 including UnitedHeath, SalesForce, and Amazon.
The UnitedHealth (UNH) stock price dropped by 32% in 2025, making it the worst-performing company in the Dow Jones Index. This crash pushed its market capitalization from a peak of $541 billion in Apr...
UnitedHealth (UNH) has encountered difficulties in the past. Its stock has decreased by over 30% within less than two months on two separate occasions in recent years, erasing billions in market capit...
High-yielding Dow stocks outperformed the broader market this year. Will new Dow dogs Home Depot, Nike, and UnitedHealth keep the streak going?
UnitedHealth, a managed healthcare firm that provides health insurance, pharmacy benefit management, and care delivery to millions of clients, is now a $297 billion (by market cap) healthcare behemoth...
The sale of underperforming assets to lessen stockholders' tax burden can render some stocks undervalued. An Evercore screen can help you find names that can bounce back.
UnitedHealth Group has laid off dozens of remote employees in healthcare technology and services marketing from its Optum unit, who were given two weeks notice in November, sources told Health Payer S...
UnitedHealth Group released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific ...
UnitedHealth said on Friday that audits by outside consulting firms of its health services and pharmacy benefit units would result in operational changes including more automation and increased standa...
UnitedHealth Group Incorporated has stabilized after recent headwinds, with profits recovering, and the foundation set for renewed growth. UNH's Q4 2025 dividend was raised 5.2% year-over-year, signal...
UnitedHealth has shown considerable rally potential, with several instances of gains exceeding 30% within two months recorded in crucial years 2010, 2019, 2020, 2021, and 2025. Importantly, it achieve...
UnitedHealth is well positioned for a potential recovery after two challenging years marked by cyberattacks, leadership turnover, and ongoing regulatory investigations. All major negative news appears...
UnitedHealth remains a "Buy" with a $400 price target, reflecting 19% upside and continued market outperformance potential. UNH delivered a Q3 2025 double-beat, posting 12% revenue growth and exceedin...
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) will release its full year 2025 financial results and provide 2026 financial guidance on Tuesday, January 27, 2026, before the market opens, and will ...
UnitedHealth crashed over 40% YTD as seniors' utilization spiked and MLR neared 90%, but the stock has already rebounded ~25% since my mid‑May Buy. The Q3 showed 12% revenue growth and a 4% EPS beat d...
UnitedHealth Group remains a core dividend growth holding, benefiting from demographic tailwinds and a dominant healthcare ecosystem role. Despite a 41.1% EPS drop in 2025 from elevated medical care r...
The healthcare sector of the U.S. stock market as a whole is cheaply priced, which can make it attractive to investors concerned that the S&P 500 has gotten too expensive several years into a bull mar...
UnitedHealth's stock has generally underperformed compared to some rivals over the last year, but how does it stand against competitors in the ever-changing healthcare landscape? An in-depth analysis ...
UnitedHealth's stock has generally underperformed compared to some rivals over the last year, but how does it stand against competitors in the ever-changing healthcare landscape? An in-depth analysis ...
West Virginia sued United HealthGroup on Monday in federal court, alleging that the company's pharmacy benefit manager Optum fueled the state's opioid crisis by oversupplying its communities with addi...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2025 | 19.44B | -6.09% | Est @-6.1% |
| 2026 | 18.18B | -6.49% | Analyst x3 |
| 2027 | 21.24B | 16.83% | Analyst x2 |
| 2028 | 23.61B | 11.16% | Analyst x1 |
| 2029 | 27.15B | 14.97% | Analyst x1 |
| 2030 | 29.17B | 7.46% | Est @7.5% |
| 2031 | 30.91B | 5.96% | Est @6.0% |
| 2032 | 32.43B | 4.91% | Est @4.9% |
| 2033 | 33.78B | 4.17% | Est @4.2% |
| 2034 | 34.93B | 3.41% | Est @3.4% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2023A | 25.68B | 1.00 | 25.68B |
| 2024A | 20.71B | 1.00 | 20.71B |
| 2025E | 19.44B | 1.07 | 18.09B |
| 2026E | 18.18B | 1.15 | 15.74B |
| 2027E | 21.24B | 1.24 | 17.11B |
| 2028E | 23.61B | 1.33 | 17.70B |
| 2029E | 27.15B | 1.43 | 18.93B |
| 2030E | 29.17B | 1.54 | 18.93B |
| 2031E | 30.91B | 1.66 | 18.67B |
| 2032E | 32.43B | 1.78 | 18.22B |
| 2033E | 33.78B | 1.91 | 17.66B |
| 2034E | 34.93B | 2.06 | 16.99B |
| Terminal | 720.30B | 2.06 | 350.45B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.
